Uberto pagotto
Uberto pagotto
Unknown affiliation
Verified email at unibo.it
Cited by
Cited by
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
LF Van Gaal, AM Rissanen, AJ Scheen, O Ziegler, S Rössner, ...
The Lancet 365 (9468), 1389-1397, 2005
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
D Cota, G Marsicano, M Tschöp, Y Grübler, C Flachskamm, M Schubert, ...
The Journal of clinical investigation 112 (3), 423-431, 2003
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
U Pagotto, G Marsicano, D Cota, B Lutz, R Pasquali
Endocrine reviews 27 (1), 73-100, 2006
Obesity and the polycystic ovary syndrome
A Gambineri, C Pelusi, V Vicennati, U Pagotto, R Pasquali
International journal of obesity 26 (7), 883-896, 2002
Pharmacological management of obesity: an Endocrine Society clinical practice guideline
CM Apovian, LJ Aronne, DH Bessesen, ME McDonnell, MH Murad, ...
The Journal of Clinical Endocrinology & Metabolism 100 (2), 342-362, 2015
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
I Matias, MP Gonthier, P Orlando, V Martiadis, L De Petrocellis, C Cervino, ...
The Journal of Clinical Endocrinology & Metabolism 91 (8), 3171-3180, 2006
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity
E Bugianesi, U Pagotto, R Manini, E Vanni, A Gastaldelli, R de Iasio, ...
The journal of clinical endocrinology & metabolism 90 (6), 3498-3504, 2005
The impact of obesity on reproduction in women with polycystic ovary syndrome
R Pasquali, A Gambineri, U Pagotto
BJOG: An International Journal of Obstetrics & Gynaecology 113 (10), 1148-1159, 2006
Endogenous cannabinoid system as a modulator of food intake
D Cota, G Marsicano, B Lutz, V Vicennati, GK Stalla, R Pasquali, ...
International journal of obesity 27 (3), 289-301, 2003
The hypothalamic‐pituitary‐adrenal axis activity in obesity and the metabolic syndrome
R Pasquali, V Vicennati, M Cacciari, U Pagotto
Annals of the New York Academy of Sciences 1083 (1), 111-128, 2006
Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels
U Pagotto, A Gambineri, V Vicennati, ML Heiman, M Tschöp, R Pasquali
The Journal of Clinical Endocrinology & Metabolism 87 (12), 5625-5629, 2002
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's …
G Di Dalmazi, V Vicennati, S Garelli, E Casadio, E Rinaldi, E Giampalma, ...
The lancet Diabetes & endocrinology 2 (5), 396-405, 2014
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome
A Gambineri, C Pelusi, S Genghini, AM Morselli‐Labate, M Cacciari, ...
Clinical endocrinology 60 (2), 241-249, 2004
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression
M Theodoropoulou, J Zhang, S Laupheimer, M Paez-Pereda, C Erneux, ...
Cancer research 66 (3), 1576-1582, 2006
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo …
A Gambineri, L Patton, A Vaccina, M Cacciari, AM Morselli-Labate, ...
The Journal of Clinical Endocrinology & Metabolism 91 (10), 3970-3980, 2006
Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function
D Cota, MA Steiner, G Marsicano, C Cervino, JP Herman, Y Grubler, ...
Endocrinology 148 (4), 1574-1581, 2007
Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors
A Gambineri, C Pelusi, E Manicardi, V Vicennati, M Cacciari, ...
Diabetes 53 (9), 2353-2358, 2004
CB1 signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance
C Quarta, L Bellocchio, G Mancini, R Mazza, C Cervino, LJ Braulke, ...
Cell metabolism 11 (4), 273-285, 2010
Retinoic acid prevents experimental Cushing syndrome
M Páez-Pereda, D Kovalovsky, U Hopfner, M Theodoropoulou, U Pagotto, ...
The Journal of clinical investigation 108 (8), 1123-1131, 2001
Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study
A Gambineri, L Patton, P Altieri, U Pagotto, C Pizzi, L Manzoli, R Pasquali
Diabetes 61 (9), 2369-2374, 2012
The system can't perform the operation now. Try again later.
Articles 1–20